Research Areas

Explore the scientific advances driving more specific, potent, and adaptable antibody-based therapies.

Explore how digital PCR is reshaping sterility testing to support faster, more reliable release of advanced therapy medicinal products.

Explore how breakthroughs in fast confocal imaging and 3D cell culture converged to transform the study of complex human biology in vitro.

High-throughput T-cell receptor sequencing reveals shared immune signatures in celiac disease, opening the door to earlier, less invasive diagnosis and disease monitoring.

As CROs and CDMOs expand their role in biopharma development and manufacturing, fast, accurate bioanalytic technologies remain critical to biotherapeutic affordability

In this two-day symposium, explore the scientific and practical advances shaping how cell and gene therapies are developed, delivered, and brought to patients.

The industry moves from task copilots to integrated discovery systems.

Generic and biosimilar competition is poised to disrupt billions in annual drug sales, reshaping market dynamics for some of the industry’s most important medicines.

Emerging clinical trials suggest that the gut microbiome plays a decisive role in how patients respond to immunotherapy.

Live-cell assays quantify the genetic and metabolic influence on drug selectivity, enabling the development of more precise cancer therapies.